Patterns of Tissue NGS Alterations are Associated with ctDNA Shedding in Non Small Cell Lung Cancer Tumors Harboring EGFR Mutations

被引：0
|
作者：
Di Lello, A. [1 ]
Torri, V. [2 ]
Behera, V. [1 ]
Wu, S. [1 ]
Hines, J. B. [1 ]
Bestvina, C. M. [1 ]
Thawani, R. [1 ]
Dolezal, J. M. [1 ]
Chin, J. [1 ]
Pezeshk, A. [1 ]
Esposito, A. [1 ]
Sacco, M. [1 ]
Husain, A. N. [1 ]
Segal, J. [1 ]
Wang, P. [1 ]
Vokes, E. [1 ]
Garassino, M. C. [1 ]
Cameron, R. B. [1 ]
机构：
[1] Univ Chicago, Chicago, IL USA
[2] Mario Negri Inst Pharmacol Res IRCCS, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06D.13
引用
收藏
页码：S327 / S328
页数：2
相关论文
共 50 条
  • [31] MILIARY METASTASES ARE ASSOCIATED WITH EGFR MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Hsu, Fred
    Toriumi, Ted
    De Caluwe, Alex
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S57 - S57
  • [32] EGFR mutations in non-small-cell lung cancer reply
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    LANCET ONCOLOGY, 2010, 11 (05): : 413 - 413
  • [33] Feasibility and Clinical Utility of ctDNA for Detection of Sensitizing and Resistance EGFR Mutations in Patients with Non-small Cell Lung Cancer
    De Herreros, M. Garcia
    Teixido, C.
    Diez, V.
    Arcocha, A.
    Reyes, R.
    Albarran-Artahona, V.
    Marin, E.
    Galvan, P.
    Padrosa, D. Martinez J.
    Vegas, L.
    Castillo, O.
    Prat, A.
    Vinolas, N.
    Reguart, N.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S449 - S449
  • [34] The significance of drug-tolerant cells by EGFR-TKIs in non-small cell lung cancer cells harboring with EGFR mutations
    Yamada, Tadaaki
    Yano, Seiji
    CANCER SCIENCE, 2021, 112 : 443 - 443
  • [35] Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Kogure, Yoshihito
    Saka, Hideo
    Oki, Masahide
    Saito, Toshiki I.
    Ahmed, Shimaa Nour Moursi
    Kitagawa, Chiyoe
    Imaizumi, Kazuyoshi
    PLOS ONE, 2015, 10 (08):
  • [36] The Efficacy of Gefitinib for Non-Adeno Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations A Pooled Analysis
    Shukuya, Takehito
    Takahashi, Toshiaki
    Ono, Akira
    Nakamura, Yukiko
    Tsuya, Asuka
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S393 - S393
  • [37] Serum carcinoembryonic antigen levels predicts the efficacy of EGFR-TKI in non-small cell lung cancer harboring EGFR mutations
    Zhang Yanwei
    Jin Bo
    Lou Yuqing
    Li Rong
    Zhang Xueyan
    Hu Song
    Han Baohui
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) : 254 - 258
  • [38] Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Zhang, Minghui
    Liu, Mingyang
    Wang, Yan
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : E1293 - E1295
  • [39] ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer
    Desai, Aakash
    Vazquez, Tadana A.
    Arce, Keishla M.
    Corassa, Marcelo
    Mack, Philip C.
    Gray, Jhanelle E.
    Pellini, Bruna
    CANCERS, 2024, 16 (05)
  • [40] Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
    Wang, Fang
    Diao, Xia-Yao
    Zhang, Xiao
    Shao, Qiong
    Feng, Yan-Fen
    An, Xin
    Wang, Hai-Yun
    CANCER COMMUNICATIONS, 2019, 39
12345